Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Commercial and Pipeline Insight: Allergic Rhinitis' returned 2 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Pipeline and Commercial Insight: Allergic Rhinitis - Immunotherapy Growth Surpassed by Generic Erosion   Datamonitor, July 2010, Pages: 220 - Insight and analysis of market potential including commercial opportunity, epidemiology and discussion of unmet needs - Assessment of key drug classes for allergic rhinitis, with analysis of impacting Nycomed S.C.A. SICAR: PharmaVitae Profile   Datamonitor, July 2010, Pages: 75 specialist Sepracor Asthma market overview Ciclesonide safety advantages could help overcome barriers to uptake Alvesco forecast assumptions Omnaris Overview Sales forecast Allergic rhinitis launch adds Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network